He has practiced as both a Certified Public Accountant and a lawyer. His practice includes M&A advisory, IP licensing, public and private debt and equity offerings, and VC investments. He was formerly a partner at the law firm of Lane Powell. His biotech experience includes serving as CFO of Nura, Inc. when it was acquired by Omeros, and as Executive Vice President, CFO, and General Counsel of Northwest Biotherapeutics, Inc.